NFE2L2 and breast cancer: Mechanistically, NRF2 and MZF-1 were found to directly induce FPN gene expression and their content was markedly reduced in tumor specimens from BC patients compared to normal tissues, indicating that NRF2 can drive tumorigenesis by also restricting iron egression through decreased FPN induction [137].